The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2015
Filed:
Jul. 18, 2013
Applicant:
British Columbia Cancer Agency Branch, Vancouver, CA;
Inventors:
Ryan D. Morin, Coquitlam, CA;
Marco A. Marra, Vancouver, CA;
Randy D. Gascoyne, Vancouver, CA;
Joseph M. Connors, Vancouver, CA;
Assignee:
British Columbia Cancer Agency Branch, Vancouver, CA;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); C12N 9/10 (2006.01); C07K 16/40 (2006.01); G01N 33/68 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12N 9/1007 (2013.01); C07K 16/40 (2013.01); G01N 33/6872 (2013.01); G01N 33/57407 (2013.01); G01N 2800/52 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Y 201/01043 (2013.01);
Abstract
The disclosure provides a method of identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) such as testing a sample from a subject for a mutation in one or more biomarkers. Also described are methods for classifying or monitoring a subject having, or suspected of having, B-cell non-Hodgkin lymphoma comprising testing the sample for a mutation in one or more biomarkers.